Natera - We are delighted to welcome leading oncology surgeon and researcher, Dr. Monica Bertagnolli, to our board of directors! Read more: https://www.natera.com/press-releases/natera-appoints-dr-monica-bertagnolli-its-board-directors | Facebook
Natera Recognized as a 'Force for Change' by Leading Women Entrepreneurs (LWE) | Natera
Natera and CareDx Fined Millions for False Advertising Associated with Inappropriate Marketing for Testing - Center for Genomic Interpretation
André Natera Speaks to CIA Graduates | Culinary Institute of America
Natera Oncology on X: "We're excited to announce new #Signatera data at this year's virtual #ASCO meeting! Natera, along with its collaborators, will present 4 abstracts demonstrating the utility of personalized MRD
Natera Announces Real-World Data Collaboration with Merck | Natera
Natera and Copia Announce Partnership to Support Local Communities - StarVista
Natera Oncology on X: "🆕 Signatera is now covered by Medicare in stages II-III #colorectalcancer! Huge win for cancer patients and providers - expanding access to this new technology will help guide
Natera - Natera Announces Preliminary Fourth Quarter and Full Year 2023 Revenues - Natera
iotaMotion's iotaSOFT; Boston Scientific acquires Baylis; Natera's Prospera
Natera Announces Publication of Clinical Experience Study with 18,984 Twin Pregnancies Supporting Excellent Performance of Panorama™ NIPT | Natera
Natera Announces 2025 ESG Goals with Publication of 2021 Report | Natera
Natera Appoints Ruth E. Williams-Brinkley to its Board of Directors | Natera
Natera Announces Real-World Data Collaboration with Merck | Business Wire
Natera, Inc. | Investor Relations
Natera Supports Updated ISHLT Guidelines for the Care of Heart Transplant Patients | Natera
Natera on LinkedIn: Natera Announces Publication Highlighting Importance of Testing Total…
Medicare Extends Coverage of Natera's Signatera™ MRD Test to Ovarian Cancer and Neoadjuvant Breast Cancer | NTRA Stock News
Natera est sélectionnée pour une étude longitudinale de l'ADN tumoral circulant dans le cadre du cancer du sein
Discoveries in Health Policy: Natera Wins Injunction re MRD Testing (versus NeoGenomics)
Natera: Pioneers In Deceptive Medical Billing – Hindenburg Research
Natera Portal - April 2021 Babies | Forums | What to Expect
Looking Beyond NIPT, Natera Eyes Cancer, Transplant Testing Growth
Natera Provides Update on Ravgen Trial
We are proud to collaborate with MENARINI Group and Natera Oncology on EORTC 2129-BCG TREAT ctDNA - EORTC - OncoDaily
George Lopez Foundation and Natera Join Forces for Kidney Week to Raise Awareness about Kidney Health — George Lopez Foundation
Natera files patent lawsuit over DNA technology | Life Sciences Intellectual Property Review
